Hemodialysis access thrombosis

Keith Bertram Quencer, Rahmi Oklu

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.

Original languageEnglish (US)
Pages (from-to)S299-S308
JournalCardiovascular Diagnosis and Therapy
Volume7
DOIs
StatePublished - Dec 1 2017

Fingerprint

Thrombectomy
Renal Dialysis
Dialysis
Mechanical Thrombolysis
Thrombosis
Inpatients
Catheters
Equipment and Supplies

Keywords

  • Arteriovenous fistula (AVF)
  • Arteriovenous graft (AVG)
  • AV access thrombosis
  • Pulse spray aided pharmacomechanical thrombolysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hemodialysis access thrombosis. / Quencer, Keith Bertram; Oklu, Rahmi.

In: Cardiovascular Diagnosis and Therapy, Vol. 7, 01.12.2017, p. S299-S308.

Research output: Contribution to journalReview article

Quencer, Keith Bertram ; Oklu, Rahmi. / Hemodialysis access thrombosis. In: Cardiovascular Diagnosis and Therapy. 2017 ; Vol. 7. pp. S299-S308.
@article{70c5b8e6efcd4409b153cc7f3ba6335d,
title = "Hemodialysis access thrombosis",
abstract = "For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.",
keywords = "Arteriovenous fistula (AVF), Arteriovenous graft (AVG), AV access thrombosis, Pulse spray aided pharmacomechanical thrombolysis",
author = "Quencer, {Keith Bertram} and Rahmi Oklu",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/cdt.2017.09.08",
language = "English (US)",
volume = "7",
pages = "S299--S308",
journal = "Cardiovascular Diagnosis and Therapy",
issn = "2223-3652",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Hemodialysis access thrombosis

AU - Quencer, Keith Bertram

AU - Oklu, Rahmi

PY - 2017/12/1

Y1 - 2017/12/1

N2 - For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.

AB - For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.

KW - Arteriovenous fistula (AVF)

KW - Arteriovenous graft (AVG)

KW - AV access thrombosis

KW - Pulse spray aided pharmacomechanical thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=85038627803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038627803&partnerID=8YFLogxK

U2 - 10.21037/cdt.2017.09.08

DO - 10.21037/cdt.2017.09.08

M3 - Review article

AN - SCOPUS:85038627803

VL - 7

SP - S299-S308

JO - Cardiovascular Diagnosis and Therapy

JF - Cardiovascular Diagnosis and Therapy

SN - 2223-3652

ER -